Literature DB >> 27128445

Assessment of Glioma Response to Radiotherapy Using Multiple MRI Biomarkers with Manual and Semiautomated Segmentation Algorithms.

Yang Yu1,2, Dong-Hoon Lee1, Shin-Lei Peng1, Kai Zhang1, Yi Zhang1, Shanshan Jiang1, Xuna Zhao1, Hye-Young Heo1, Xiangyang Wang1,3, Min Chen3, Hanzhang Lu1, Haiyun Li1, Jinyuan Zhou4.   

Abstract

BACKGROUND AND
PURPOSE: Multimodality magnetic resonance imaging (MRI) can provide complementary information in the assessment of brain tumors. We aimed to segment tumor in amide proton transfer-weighted (APTw) images and to investigate multiparametric MRI biomarkers for the assessment of glioma response to radiotherapy. For tumor extraction, we evaluated a semiautomated segmentation method based on region of interest (ROI) results by comparing it with the manual segmentation method.
METHODS: Thirteen nude rats injected with U87 tumor cells were irradiated by an 8-Gy radiation dose. All MRI scans were performed on a 4.7-T animal scanner preradiation, and at day 1, day 4, and day 8 postradiation. Two experts performed manual and semiautomated methods to extract tumor ROIs on APTw images. Multimodality MRI signals of the tumors, including structural (T2 and T1 ), functional (apparent diffusion coefficient and blood flow), and molecular (APTw and magnetization transfer ratio or MTR), were calculated and compared quantitatively.
RESULTS: The semiautomated method provided more reliable tumor extraction results on APTw images than the manual segmentation, in less time. A considerable increase in the ADC intensities of the tumor was observed during the postradiation. A steady decrease in the blood flow values and in the APTw signal intensities were found after radiotherapy.
CONCLUSIONS: The semiautomated method of tumor extraction showed greater efficiency and stability than the manual method. Apparent diffusion coefficient, blood flow, and APTw are all useful biomarkers in assessing glioma response to radiotherapy.
Copyright © 2016 by the American Society of Neuroimaging.

Entities:  

Keywords:  APT imaging; Brain tumor; image segmentation; multiparametric MRI; response assessment

Mesh:

Substances:

Year:  2016        PMID: 27128445      PMCID: PMC5083211          DOI: 10.1111/jon.12354

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  51 in total

1.  Normal brain and brain tumor: multicomponent apparent diffusion coefficient line scan imaging.

Authors:  S E Maier; P Bogner; G Bajzik; H Mamata; Y Mamata; I Repa; F A Jolesz; R V Mulkern
Journal:  Radiology       Date:  2001-06       Impact factor: 11.105

2.  Quantification of tumour response to radiotherapy.

Authors:  Q Y Gong; P R Eldridge; A R Brodbelt; M García-Fiñana; A Zaman; B Jones; N Roberts
Journal:  Br J Radiol       Date:  2004-05       Impact factor: 3.039

3.  Amide proton transfer imaging of human brain tumors at 3T.

Authors:  Craig K Jones; Michael J Schlosser; Peter C M van Zijl; Martin G Pomper; Xavier Golay; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2006-09       Impact factor: 4.668

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Imaging of Primary Brain Tumors and Metastases with Fast Quantitative 3-Dimensional Magnetization Transfer.

Authors:  Meritxell Garcia; Monika Gloor; Oliver Bieri; Ernst-Wilhelm Radue; Johanna M Lieb; Dominik Cordier; Christoph Stippich
Journal:  J Neuroimaging       Date:  2015-02-20       Impact factor: 2.486

6.  Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.

Authors:  Nail Bulakbasi; Murat Kocaoglu; Fatih Ors; Cem Tayfun; Taner Uçöz
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

7.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo.

Authors:  S D Wolff; R S Balaban
Journal:  Magn Reson Med       Date:  1989-04       Impact factor: 4.668

Review 8.  Pseudoprogression and pseudoresponse in the treatment of gliomas.

Authors:  Dieta Brandsma; Martin J van den Bent
Journal:  Curr Opin Neurol       Date:  2009-12       Impact factor: 5.710

9.  Magnetic resonance image-guided proteomics of human glioblastoma multiforme.

Authors:  Susan K Hobbs; Gongyi Shi; Ron Homer; Griff Harsh; Scott W Atlas; Mark D Bednarski
Journal:  J Magn Reson Imaging       Date:  2003-11       Impact factor: 4.813

10.  Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function.

Authors:  Thomas E Merchant; Chia-Ho Hua; Hemant Shukla; Xiaofei Ying; Simeon Nill; Uwe Oelfke
Journal:  Pediatr Blood Cancer       Date:  2008-07       Impact factor: 3.167

View more
  5 in total

Review 1.  Magnetic resonance imaging-guided radiation therapy using animal models of glioblastoma.

Authors:  Christian Vanhove; Ingeborg Goethals
Journal:  Br J Radiol       Date:  2019-01-17       Impact factor: 3.039

Review 2.  The Applicability of Amide Proton Transfer Imaging in the Nervous System: Focus on Hypoxic-Ischemic Encephalopathy in the Neonate.

Authors:  Yang Zheng; Xiaoming Wang
Journal:  Cell Mol Neurobiol       Date:  2017-09-23       Impact factor: 5.046

3.  Rapid and quantitative chemical exchange saturation transfer (CEST) imaging with magnetic resonance fingerprinting (MRF).

Authors:  Ouri Cohen; Shuning Huang; Michael T McMahon; Matthew S Rosen; Christian T Farrar
Journal:  Magn Reson Med       Date:  2018-05-13       Impact factor: 4.668

Review 4.  Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives.

Authors:  N M deSouza; J M Winfield; J C Waterton; A Weller; M-V Papoutsaki; S J Doran; D J Collins; L Fournier; D Sullivan; T Chenevert; A Jackson; M Boss; S Trattnig; Y Liu
Journal:  Eur Radiol       Date:  2017-09-27       Impact factor: 5.315

5.  Evaluation of Temozolomide Treatment for Glioblastoma Using Amide Proton Transfer Imaging and Diffusion MRI.

Authors:  Ryutarou Onishi; Reika Sawaya; Keiho Tsuji; Narumi Arihara; Akiko Ohki; Junpei Ueda; Junichi Hata; Shigeyoshi Saito
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.